{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:40:02Z","timestamp":1792701602036,"version":"4.5.0"},"reference-count":227,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"vor","delay-in-days":5520,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.nurt.2008.05.006","type":"journal-article","created":{"date-parts":[[2008,7,13]],"date-time":"2008-07-13T04:34:29Z","timestamp":1215923669000},"page":"443-457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"title":["Tau-Based Treatment Strategies in Neurodegenerative Diseases"],"prefix":"10.1016","volume":"5","author":[{"given":"Anja","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckhard","family":"Mandelkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nurt.2008.05.006_bib1","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","article-title":"A protein factor essential for microtubule assembly","volume":"72","author":"Weingarten","year":"1975","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.05.006_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0022-2836(77)90213-3","article-title":"Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin","volume":"116","author":"Cleveland","year":"1977","journal-title":"J Mol Biol"},{"key":"10.1016\/j.nurt.2008.05.006_bib3","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1083\/jcb.98.3.1090","article-title":"Studies on the expression of the microtubule-associated protein, tau, during mouse brain development, with newly isolated complementary DNA probes","volume":"98","author":"Drubin","year":"1984","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nurt.2008.05.006_bib4","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1083\/jcb.101.4.1371","article-title":"The distribution of tau in the mammalian central nervous system","volume":"101","author":"Binder","year":"1985","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nurt.2008.05.006_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0092-8674(86)90318-1","article-title":"Beyond self-assembly: from microtubules to morphogenesis","volume":"45","author":"Kirschner","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.nurt.2008.05.006_bib6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/343461a0","article-title":"Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons","volume":"343","author":"Caceres","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.nurt.2008.05.006_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1242\/jcs.1986.Supplement_5.11","article-title":"Vesicle movements and microtubule-based motors","volume":"5","author":"Sheetz","year":"1986","journal-title":"J Cell Sci Suppl"},{"key":"10.1016\/j.nurt.2008.05.006_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1073\/pnas.72.1.177","article-title":"Cyclic AMP-dependent endogenous phosphorylation of a microtubule-associated protein","volume":"72","author":"Sloboda","year":"1975","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.05.006_bib9","first-page":"125","article-title":"Microtubule-associated proteins, phosphorylation gradients, and the establishment of neuronal polarity","volume":"4","author":"Mandell","year":"1996","journal-title":"Perspect Dev Neurobiol"},{"key":"10.1016\/j.nurt.2008.05.006_bib10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.3122323","article-title":"The primary structure and heterogeneity of tau protein from mouse brain","volume":"239","author":"Lee","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.nurt.2008.05.006_bib11","doi-asserted-by":"crossref","first-page":"24290","DOI":"10.1016\/S0021-9258(19)51080-8","article-title":"Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for \u03b2-structure","volume":"269","author":"Schweers","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib12","doi-asserted-by":"crossref","first-page":"10626","DOI":"10.1021\/bi00158a027","article-title":"Structure and novel exons of the human tau gene","volume":"31","author":"Andreadis","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.nurt.2008.05.006_bib13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","article-title":"Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease","volume":"3","author":"Goedert","year":"1989","journal-title":"Neuron"},{"key":"10.1016\/j.nurt.2008.05.006_bib14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1242\/jcs.110.6.789","article-title":"The \u2018jaws\u2019 model of tau-microtubule interaction examined in CHO cells","volume":"110","author":"Preuss","year":"1997","journal-title":"J Cell Sci"},{"key":"10.1016\/j.nurt.2008.05.006_bib15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1083\/jcb.115.3.717","article-title":"Tau protein binds to microtubules through a flexible array of distributed weak sites","volume":"115","author":"Butner","year":"1991","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nurt.2008.05.006_bib16","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1083\/jcb.124.5.769","article-title":"Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau","volume":"124","author":"Goode","year":"1994","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nurt.2008.05.006_bib17","doi-asserted-by":"crossref","first-page":"9548","DOI":"10.1073\/pnas.1633508100","article-title":"Differential regulation of microtubule dynamics by three- and four-repeat tau: implications for the onset of neurodegenerative disease","volume":"100","author":"Panda","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.05.006_bib18","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0306-4522(94)00598-Y","article-title":"The expression and distribution of tau proteins and messenger RNA in rat dorsal root ganglion neurons during development and regeneration","volume":"66","author":"Nothias","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.nurt.2008.05.006_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0896-6273(93)90279-Z","article-title":"Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding","volume":"11","author":"Biernat","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.nurt.2008.05.006_bib20","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0896-6273(93)90057-X","article-title":"Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding","volume":"10","author":"Bramblett","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.nurt.2008.05.006_bib21","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1083\/jcb.107.4.1449","article-title":"Tau proteins: the molecular structure and mode of binding on microtubules","volume":"107","author":"Hirokawa","year":"1988","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nurt.2008.05.006_bib22","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/360674a0","article-title":"Projection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons","volume":"360","author":"Chen","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.nurt.2008.05.006_bib23","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0896-6273(00)80250-0","article-title":"Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A","volume":"17","author":"Sontag","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.nurt.2008.05.006_bib24","doi-asserted-by":"crossref","first-page":"17957","DOI":"10.1074\/jbc.M400351200","article-title":"Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival","volume":"279","author":"Shimura","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib25","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.1016\/S0021-9258(18)32333-0","article-title":"Phosphorylation of microtubule-associated proteins regulates their interaction with actin filaments","volume":"258","author":"Selden","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib26","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1083\/jcb.143.3.777","article-title":"Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease","volume":"143","author":"Ebneth","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nurt.2008.05.006_bib27","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.neurobiolaging.2003.04.007","article-title":"Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses","volume":"24","author":"Mandelkow","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.nurt.2008.05.006_bib28","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1093\/emboj\/cdf503","article-title":"Single-molecule investigation of the interference between kinesin, tau and MAP2c","volume":"21","author":"Seitz","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.nurt.2008.05.006_bib29","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1126\/science.1152993","article-title":"Differential regulation of dynein and kinesin motor proteins by tau","volume":"319","author":"Dixit","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.nurt.2008.05.006_bib30","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1083\/jcb.200108057","article-title":"Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress","volume":"156","author":"Stamer","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nurt.2008.05.006_bib31","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1523\/JNEUROSCI.4674-06.2007","article-title":"Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2\/Par-1","volume":"27","author":"Thies","year":"2007","journal-title":"J Neurosci"},{"issue":"8515","key":"10.1016\/j.nurt.2008.05.006_bib32","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(86)90495-2","article-title":"Alzheimer's disease and tau proteins","volume":"2","author":"Brion","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.nurt.2008.05.006_bib33","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","article-title":"Microtubule-associated protein tau: a component of Alzheimer paired helical filaments","volume":"261","author":"Grundke-Iqbal","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2990.1994.tb00951.x","article-title":"Hirano bodies and related neuronal inclusions","volume":"20","author":"Hirano","year":"1994","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.nurt.2008.05.006_bib35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1440-1789.2006.00669.x","article-title":"Ultrastructural characteristics of tau filaments in tauopathies: immuno-electron microscopic demonstration of tau filaments in tauopathies","volume":"26","author":"Arima","year":"2006","journal-title":"Neuropathology"},{"key":"10.1016\/j.nurt.2008.05.006_bib36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0197-0186(01)00054-7","article-title":"Pathological glial tau accumulations in neurodegenerative disease: review and case report","volume":"39","author":"Berry","year":"2001","journal-title":"Neurochem Int"},{"key":"10.1016\/j.nurt.2008.05.006_bib37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1006\/exnr.2000.7380","article-title":"Alzheimer-related tau-pathology in the perforant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia","volume":"163","author":"Thal","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nurt.2008.05.006_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S1461145705005833","article-title":"Targeting acetylcholinesterase and butyrylcholinesterase in dementia","volume":"9","author":"Lane","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.nurt.2008.05.006_bib39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/jnnp.71.3.401","article-title":"Highly increased CSF tau protein and decreased \u03b2-amyloid1-42 in sporadic CJD: a discrimination from Alzheimer's disease?","volume":"71","author":"Kapaki","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nurt.2008.05.006_bib40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02815140","article-title":"Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?","volume":"26","author":"Blennow","year":"1995","journal-title":"Mol Chem Neuropathol"},{"key":"10.1016\/j.nurt.2008.05.006_bib41","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s007020070079","article-title":"CSF levels of tau, \u03b2-amyloid1-42 and GAP-43 in frontotemporal dementia, other types of dementia and normal aging","volume":"107","author":"Sj\u00f6gren","year":"2000","journal-title":"J Neural Transm"},{"key":"10.1016\/j.nurt.2008.05.006_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jcp.20602","article-title":"Cerebrospinal fluid tau, A\u03b2, and phosphorylated tau protein for the diagnosis of Alzheimer's disease","volume":"208","author":"Formichi","year":"2006","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.nurt.2008.05.006_bib43","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00702-003-0017-7","article-title":"CSF-tau, CSF-A\u03b21-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity","volume":"110","author":"Ganzer","year":"2003","journal-title":"J Neural Transm"},{"key":"10.1016\/j.nurt.2008.05.006_bib44","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient Alzheimer's disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nurt.2008.05.006_bib45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00702-003-0065-z","article-title":"Core biological marker candidates of Alzheimer's disease: perspectives for diagnosis, prediction of outcome and reflection of biological activity","volume":"111","author":"Hampel","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1016\/j.nurt.2008.05.006_bib46","doi-asserted-by":"crossref","DOI":"10.1080\/15622970701535502","article-title":"Do CSF total tau, phosphorylated tau, and \u03b2-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease?","author":"Diniz","year":"2008","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.nurt.2008.05.006_bib47","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1212\/01.wnl.0000286944.22262.ff","article-title":"Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI","volume":"69","author":"Ewers","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.05.006_bib48","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1212\/01.wnl.0000183284.92920.f2","article-title":"Phosphorylated tau predicts rate of cognitive decline in MCI subjects: a comparative CSF study","volume":"65","author":"Buerger","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.05.006_bib49","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMoa054625","article-title":"PET of brain amyloid and tau in mild cognitive impairment","volume":"355","author":"Small","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2008.05.006_bib50","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2008.05.006_bib51","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.410430617","article-title":"Tau is a candidate gene for chromosome 17 frontotemporal dementia","volume":"43","author":"Poorkaj","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2008.05.006_bib52","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/31508","article-title":"Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17","volume":"393","author":"Hutton","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.nurt.2008.05.006_bib53","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1073\/pnas.95.13.7737","article-title":"Mutation in the tau gene in familial multiple system tauopathy with presenile dementia","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.05.006_bib54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0014-5793(98)01217-4","article-title":"Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly","volume":"437","author":"Hasegawa","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nurt.2008.05.006_bib55","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1126\/science.282.5395.1914","article-title":"Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17","volume":"282","author":"Hong","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.nurt.2008.05.006_bib56","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0014-5793(99)00222-7","article-title":"Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation","volume":"446","author":"Dayanandan","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nurt.2008.05.006_bib57","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0014-5793(99)00294-X","article-title":"Accelerated filament formation from tau protein with specific FTDP-17 missense mutations","volume":"447","author":"Nacharaju","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nurt.2008.05.006_bib58","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0014-5793(99)00508-6","article-title":"Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments","volume":"450","author":"Goedert","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nurt.2008.05.006_bib59","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1021\/bi000201f","article-title":"In vitro polymerization of tau protein monitored by laser light scattering: method and application to the study of FTDP-17 mutants","volume":"39","author":"Gamblin","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.nurt.2008.05.006_bib60","doi-asserted-by":"crossref","first-page":"11714","DOI":"10.1021\/bi000850r","article-title":"Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias","volume":"39","author":"Barghorn","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.nurt.2008.05.006_bib61","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1073\/pnas.96.10.5598","article-title":"Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements","volume":"96","author":"D'Souza","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.05.006_bib62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(02)00124-6","article-title":"Effects on splicing and protein function of three mutations in codon N296 of tau in vitro","volume":"323","author":"Grover","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.nurt.2008.05.006_bib63","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/hmg\/8.4.711","article-title":"Association of an extended haplotype in the tau gene with progressive supranuclear palsy","volume":"8","author":"Baker","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nurt.2008.05.006_bib64","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1212\/WNL.56.12.1702","article-title":"Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype","volume":"56","author":"Houlden","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.05.006_bib65","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jnen\/61.6.547","article-title":"Argyrophilic grain disease is a sporadic 4-repeat tauopathy","volume":"61","author":"Togo","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"issue":"67","key":"10.1016\/j.nurt.2008.05.006_bib66","first-page":"73","article-title":"Sites of phosphorylation in tau and factors affecting their regulation","author":"Anderton","year":"2001","journal-title":"Biochem Soc Symp"},{"key":"10.1016\/j.nurt.2008.05.006_bib67","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1074\/jbc.M507753200","article-title":"Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs","volume":"281","author":"Khlistunova","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib68","doi-asserted-by":"crossref","first-page":"31755","DOI":"10.1074\/jbc.M705282200","article-title":"The \u03b2-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy","volume":"282","author":"Eckermann","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib69","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1523\/JNEUROSCI.2824-07.2008","article-title":"The potential for \u03b2-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy","volume":"28","author":"Mocanu","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2008.05.006_bib70","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1091\/mbc.e07-04-0327","article-title":"Tau phosphorylation sites work in concert to promote neurotoxicity in vivo","volume":"18","author":"Steinhilb","year":"2007","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.nurt.2008.05.006_bib71","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/jnr.21232","article-title":"S\/P and T\/P phosphorylation is critical for tau neurotoxicity in Drosophila","volume":"85","author":"Steinhilb","year":"2007","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.nurt.2008.05.006_bib72","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0092-8674(04)00170-9","article-title":"PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila","volume":"116","author":"Nishimura","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.nurt.2008.05.006_bib73","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","article-title":"Tau suppression in a neurodegenerative mouse model improves memory function","volume":"309","author":"Santacruz","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.nurt.2008.05.006_bib74","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","article-title":"Tau protein isoforms, phosphorylation and role in neurodegenerative disorders","volume":"33","author":"Bu\u00e9e","year":"2000","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.nurt.2008.05.006_bib75","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00702-004-0221-0","article-title":"Post-translational modifications of tau protein in Alzheimer's disease","volume":"112","author":"Gong","year":"2005","journal-title":"J Neural Transm"},{"key":"10.1016\/j.nurt.2008.05.006_bib76","doi-asserted-by":"crossref","first-page":"8357","DOI":"10.1128\/MCB.01017-06","article-title":"Serum- and glucocorticoid-inducible kinase 1 (SGK1) increases neurite formation through microtubule depolymerization by SGK1 and by SGK1 phosphorylation of tau","volume":"26","author":"Yang","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.nurt.2008.05.006_bib77","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0092-8674(00)80208-1","article-title":"MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption","volume":"89","author":"Drewes","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.nurt.2008.05.006_bib78","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.1107403","article-title":"Mammalian SAD kinases are required for neuronal polarization","volume":"307","author":"Kishi","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.nurt.2008.05.006_bib79","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00401-002-0657-y","article-title":"Role of protein kinase B in Alzheimer's neurofibrillary pathology","volume":"105","author":"Pei","year":"2003","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nurt.2008.05.006_bib80","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0169-328X(02)00488-6","article-title":"Up-regulation of mitogen-activated protein kinases ERK1\/2 and MEK1\/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease","volume":"109","author":"Pei","year":"2002","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.nurt.2008.05.006_bib81","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1091\/mbc.9.6.1495","article-title":"The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease","volume":"9","author":"Illenberger","year":"1998","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.nurt.2008.05.006_bib82","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0197-4580(95)00027-C","article-title":"Hyperphosphorylation of tau in PHF","volume":"16","author":"Morishima-Kawashima","year":"1995","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.nurt.2008.05.006_bib83","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s004010100423","article-title":"Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease","volume":"103","author":"Augustinack","year":"2002","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nurt.2008.05.006_bib84","doi-asserted-by":"crossref","first-page":"7679","DOI":"10.1074\/jbc.270.13.7679","article-title":"Microtubule-associated protein\/microtubule affinity-regulating kinase (p110mark): a novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262","volume":"270","author":"Drewes","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib85","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular A\u03b2 and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nurt.2008.05.006_bib86","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1021\/bi981874p","article-title":"Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments","volume":"38","author":"Schneider","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.nurt.2008.05.006_bib87","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.cub.2005.12.042","article-title":"TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model","volume":"16","author":"Khurana","year":"2006","journal-title":"Curr Biol"},{"key":"10.1016\/j.nurt.2008.05.006_bib88","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1385\/JMN:19:3:261","article-title":"Discovery of compounds that will prevent tau pathology","volume":"19","author":"Kosik","year":"2002","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.nurt.2008.05.006_bib89","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1083\/jcb.200401085","article-title":"MARK\/PAR1 kinase is a regulator of microtubule-dependent transport in axons","volume":"167","author":"Mandelkow","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nurt.2008.05.006_bib90","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1091\/mbc.02-03-0046","article-title":"Protein kinase MARK\/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity","volume":"13","author":"Biernat","year":"2002","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.nurt.2008.05.006_bib91","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1093\/emboj\/cdg447","article-title":"MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK\/PAR-1","volume":"22","author":"Timm","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.nurt.2008.05.006_bib92","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/jnen\/59.11.966","article-title":"Microtubule-affinity regulating kinase (MARK) is tightly associated with neurofibrillary tangles in Alzheimer brain: a fluorescence resonance energy transfer study","volume":"59","author":"Chin","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.nurt.2008.05.006_bib93","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1091\/mbc.e05-01-0081","article-title":"PAK5 kinase is an inhibitor of MARK\/Par-1, which leads to stable microtubules and dynamic actin","volume":"16","author":"Matenia","year":"2005","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.nurt.2008.05.006_bib94","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/ncb1569","article-title":"A functional genomic screen identifies a role for TAO1 kinase in spindle-checkpoint signalling","volume":"9","author":"Draviam","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.nurt.2008.05.006_bib95","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/sj.emboj.7601668","article-title":"TAO kinases mediate activation of p38 in response to DNA damage","volume":"26","author":"Raman","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/j.nurt.2008.05.006_bib96","doi-asserted-by":"crossref","first-page":"31449","DOI":"10.1074\/jbc.M102988200","article-title":"Cofilin phosphorylation and actin reorganization activities of testicular protein kinase 2 and its predominant expression in testicular Sertoli cells","volume":"276","author":"Toshima","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib97","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1091\/mbc.e07-07-0730","article-title":"Spred1 and TESK1: two new interaction partners of the kinase MARKK\/TAO1 that link the microtubule and actin cytoskeleton","volume":"19","author":"Johne","year":"2008","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.nurt.2008.05.006_bib98","doi-asserted-by":"crossref","first-page":"21680","DOI":"10.1074\/jbc.M500752200","article-title":"Actopaxin interacts with TESK1 to regulate cell spreading on fibronectin","volume":"280","author":"LaLonde","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib99","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1042\/BJ20041181","article-title":"Sprouty-4 negatively regulates cell spreading by inhibiting the kinase activity of testicular protein kinase","volume":"387","author":"Tsumura","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.nurt.2008.05.006_bib100","doi-asserted-by":"crossref","first-page":"6533","DOI":"10.1523\/JNEUROSCI.5567-05.2006","article-title":"Phosphorylation of actin-depolymerizing factor\/cofilin by LIM-kinase mediates amyloid \u03b2-induced degeneration: a potential mechanism of neuronal dystrophy in Alzheimer's disease","volume":"26","author":"Heredia","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2008.05.006_bib101","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1074-5521(00)00063-6","article-title":"Inhibition of cyclin-dependent kinases, GSK-3\u03b2 and CK1 by hymenialdisine, a marine sponge constituent","volume":"7","author":"Meijer","year":"2000","journal-title":"Chem Biol"},{"key":"10.1016\/j.nurt.2008.05.006_bib102","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1432-1327.1998.2520542.x","article-title":"Sequential phosphorylation of Tau by glycogen synthase kinase-3\u03b2 and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation","volume":"252","author":"Zheng-Fischh\u00f6fer","year":"1998","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.nurt.2008.05.006_bib103","doi-asserted-by":"crossref","first-page":"50078","DOI":"10.1074\/jbc.M406109200","article-title":"Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain","volume":"279","author":"Liu","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib104","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0167-4781(92)90073-9","article-title":"Molecular structure of the C\u03b2 catalytic subunit of rat cAMP-dependent protein kinase and differential expression of C\u03b1 and C\u03b2 isoforms in rat tissues and cultured cells","volume":"1131","author":"Shuntoh","year":"1992","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nurt.2008.05.006_bib105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0006-8993(98)00296-0","article-title":"Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration","volume":"797","author":"Pei","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.nurt.2008.05.006_bib106","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/35012636","article-title":"Neurotoxicity induces cleavage of p35 to p25 by in","volume":"405","author":"Lee","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.nurt.2008.05.006_bib107","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0896-6273(03)00259-9","article-title":"Cdk5 is a key factor in tau aggregation and tangle formation in vivo","volume":"38","author":"Noble","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nurt.2008.05.006_bib108","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0896-6273(03)00627-5","article-title":"Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles","volume":"40","author":"Cruz","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nurt.2008.05.006_bib109","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10571-007-9224-3","article-title":"Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-\u03b2 and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies","volume":"27","author":"Lopes","year":"2007","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.nurt.2008.05.006_bib110","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1038\/sj.emboj.7600237","article-title":"A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons","volume":"23","author":"Morfini","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.nurt.2008.05.006_bib111","doi-asserted-by":"crossref","first-page":"10633","DOI":"10.1523\/JNEUROSCI.23-33-10633.2003","article-title":"Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice","volume":"23","author":"Hallows","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2008.05.006_bib112","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1471-4159.2004.03004.x","article-title":"Inhibition of neuronal apoptosis by the cyclin-dependent kinase inhibitor GW8510: identification of 3\u2032 substituted indolones as a scaffold for the development of neuroprotective drugs","volume":"93","author":"Johnson","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.nurt.2008.05.006_bib113","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1358\/dnp.2006.19.8.1043961","article-title":"The role of CDK5\/P25 formation\/inhibition in neurodegeneration","volume":"19","author":"Camins","year":"2006","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.nurt.2008.05.006_bib114","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1073\/pnas.96.9.4797","article-title":"A cyclin-dependent kinase inhibitor inducing cancer cell differentiation: biochemical identification using Xenopus egg extracts","volume":"96","author":"Rosania","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.05.006_bib115","unstructured":"Tsai LH. The inducible p25 transgenic mouse as an Alzheimer's disease model. Presented at: Alzheimer's disease: from molecular mechanisms to drug discovery, Cancun, Mexico, Dec 11-17, 2004."},{"key":"10.1016\/j.nurt.2008.05.006_bib116","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bbapap.2005.02.013","article-title":"Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions","volume":"1751","author":"Higuchi","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nurt.2008.05.006_bib117","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.drudis.2006.08.009","article-title":"The therapeutic potential of the calpain family: new aspects","volume":"11","author":"Saez","year":"2006","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.nurt.2008.05.006_bib118","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejps.2005.02.001","article-title":"Tissue distribution, pharmacokinetics and identification of roscovitine metabolites in rat","volume":"25","author":"Vita","year":"2005","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nurt.2008.05.006_bib119","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/0076-6879(91)00172-S","article-title":"cDNA cloning and properties of glycogen synthase kinase-3","volume":"200","author":"Woodgett","year":"1991","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.nurt.2008.05.006_bib120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0301-0082(01)00011-9","article-title":"The multifaceted roles of glycogen synthase kinase 3\u03b2 in cellular signaling","volume":"65","author":"Grimes","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.nurt.2008.05.006_bib121","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1242\/jcs.00384","article-title":"GSK-3: tricks of the trade for a multi-tasking kinase","volume":"116","author":"Doble","year":"2003","journal-title":"J Cell Sci"},{"key":"10.1016\/j.nurt.2008.05.006_bib122","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0960-9822(00)00246-3","article-title":"Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells","volume":"4","author":"Lovestone","year":"1994","journal-title":"Curr Biol"},{"key":"10.1016\/j.nurt.2008.05.006_bib123","doi-asserted-by":"crossref","first-page":"19547","DOI":"10.1074\/jbc.272.31.19547","article-title":"Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons","volume":"272","author":"Hong","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib124","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0014-5793(97)00688-1","article-title":"Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons","volume":"411","author":"Mu\u00f1oz-Monta\u00f1o","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nurt.2008.05.006_bib125","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1021\/bi051634r","article-title":"Glycogen synthase kinase 3\u03b2 phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism","volume":"45","author":"Li","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.nurt.2008.05.006_bib126","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00005072-199701000-00007","article-title":"Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain","volume":"56","author":"Pei","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.nurt.2008.05.006_bib127","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0896-6273(02)00706-7","article-title":"Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila","volume":"34","author":"Jackson","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.nurt.2008.05.006_bib128","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1046\/j.1471-4159.2002.01269.x","article-title":"Spatial learning deficit in transgenic mice that conditionally over-express GSK-3\u03b2 in the brain but do not form tau filaments","volume":"83","author":"Hern\u00e1ndez","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.nurt.2008.05.006_bib129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/emboj\/20.1.27","article-title":"Decreased nuclear \u03b2-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3\u03b2 conditional transgenic mice","volume":"20","author":"Lucas","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.nurt.2008.05.006_bib130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1034\/j.1399-5618.2002.01150.x","article-title":"Regulation of tau phosphorylation and protection against \u03b2-amyloid-induced neurodegeneration by lithium: possible implications for Alzheimer's disease","volume":"4","author":"Alvarez","year":"2002","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.nurt.2008.05.006_bib131","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2174\/156802606776743057","article-title":"Tau therapeutic strategies for the treatment of Alzheimer's disease","volume":"6","author":"Churcher","year":"2006","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib132","doi-asserted-by":"crossref","first-page":"45937","DOI":"10.1074\/jbc.M306268200","article-title":"Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418","volume":"278","author":"Bhat","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib133","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1146\/annurev.pharmtox.41.1.789","article-title":"Molecular targets of lithium action","volume":"41","author":"Phiel","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.nurt.2008.05.006_bib134","doi-asserted-by":"crossref","first-page":"6990","DOI":"10.1073\/pnas.0500466102","article-title":"Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo","volume":"102","author":"Noble","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.05.006_bib135","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0306-4522(02)00697-8","article-title":"Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats","volume":"118","author":"Sun","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.nurt.2008.05.006_bib136","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/exnr.2001.7630","article-title":"PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus","volume":"168","author":"Vogelsberg-Ragaglia","year":"2001","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nurt.2008.05.006_bib137","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1046\/j.1471-4159.1995.65020732.x","article-title":"Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain","volume":"65","author":"Gong","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.nurt.2008.05.006_bib138","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0002-9440(10)63445-1","article-title":"Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1\/2, MEK1\/2, and p70 S6, similar to that in Alzheimer's disease","volume":"163","author":"Pei","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nurt.2008.05.006_bib139","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.febslet.2004.04.047","article-title":"Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration","volume":"566","author":"Li","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nurt.2008.05.006_bib140","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0014-5793(96)01386-5","article-title":"RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments","volume":"399","author":"Kampers","year":"1996","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nurt.2008.05.006_bib141","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/383550a0","article-title":"Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans","volume":"383","author":"Goedert","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.nurt.2008.05.006_bib142","first-page":"1115","article-title":"Role of glycosaminoglycans in determining the helicity of paired helical filaments","volume":"151","author":"Arrasate","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nurt.2008.05.006_bib143","first-page":"2181","article-title":"Free fatty acids stimulate the polymerization of tau and amyloid \u03b2 peptides: in vitro evidence for a common effector of pathogenesis in Alzheimer's disease","volume":"150","author":"Wilson","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nurt.2008.05.006_bib144","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1073\/pnas.97.10.5129","article-title":"Assembly of \u03c4 protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming \u03b2 structure","volume":"97","author":"von Bergen","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.05.006_bib145","doi-asserted-by":"crossref","first-page":"48165","DOI":"10.1074\/jbc.M105196200","article-title":"Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local \u03b2-structure","volume":"276","author":"von Bergen","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib146","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1750-3639.2007.00053.x","article-title":"Structural principles of tau and the paired helical filaments of Alzheimer's disease","volume":"17","author":"Mandelkow","year":"2007","journal-title":"Brain Pathol"},{"key":"10.1016\/j.nurt.2008.05.006_bib147","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1083\/jcb.118.3.573","article-title":"Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro","volume":"118","author":"Wille","year":"1992","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nurt.2008.05.006_bib148","first-page":"74539","article-title":"Tau phosphorylation, aggregation, and cell toxicity","volume":"2006","author":"Avila","year":"2006","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.nurt.2008.05.006_bib149","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2174\/156720506779025279","article-title":"The role of tau phosphorylation in the pathogenesis of Alzheimer's disease","volume":"3","author":"Mi","year":"2006","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.nurt.2008.05.006_bib150","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/jnen\/64.2.104","article-title":"The role of caspase cleavage of tau in Alzheimer disease neuropathology","volume":"64","author":"Cotman","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.nurt.2008.05.006_bib151","doi-asserted-by":"crossref","first-page":"10252","DOI":"10.1073\/pnas.0703676104","article-title":"Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model","volume":"104","author":"Wang","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.05.006_bib152","doi-asserted-by":"crossref","first-page":"16454","DOI":"10.1074\/jbc.M700192200","article-title":"Tau aggregation and toxicity in a cell culture model of tauopathy","volume":"282","author":"Bandyopadhyay","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib153","doi-asserted-by":"crossref","first-page":"11213","DOI":"10.1073\/pnas.93.20.11213","article-title":"Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines","volume":"93","author":"Wischik","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.05.006_bib154","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1074\/jbc.M410984200","article-title":"Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells","volume":"280","author":"Pickhardt","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib155","doi-asserted-by":"crossref","first-page":"10016","DOI":"10.1021\/bi700878g","article-title":"Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cells","volume":"46","author":"Pickhardt","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.nurt.2008.05.006_bib156","doi-asserted-by":"crossref","first-page":"9215","DOI":"10.1002\/anie.200704051","article-title":"Rhodanine-based tau aggregation inhibitors in cell models of tauopathy","volume":"46","author":"Bulic","year":"2007","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.nurt.2008.05.006_bib157","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2174\/156720507781788765","article-title":"N-phenylamine derivatives as aggregation inhibitors in cell models of tauopathy","volume":"4","author":"Pickhardt","year":"2007","journal-title":"Curr Alzheimer Res"},{"issue":"44","key":"10.1016\/j.nurt.2008.05.006_bib158","first-page":"149","article-title":"Saturation transfer difference NMR spectroscopy for identifying ligand epitopes and binding specificities","author":"Meyer","year":"2004","journal-title":"Ernst Schering Res Found Workshop"},{"key":"10.1016\/j.nurt.2008.05.006_bib159","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/em.2860090306","article-title":"Mutagenicity testing of 5-(4\u2013nitrophenyl)-2,4-pentadien-1-al (spy dust) and its metabolites in vitro and in vivo","volume":"9","author":"Zeiger","year":"1987","journal-title":"Environ Mutagen"},{"key":"10.1016\/j.nurt.2008.05.006_bib160","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/1056-8727(96)00113-4","article-title":"Clinical investigation of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy in Japan: multicenter study","volume":"10","author":"Hotta","year":"1996","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.nurt.2008.05.006_bib161","doi-asserted-by":"crossref","first-page":"10227","DOI":"10.1021\/bi050387o","article-title":"Cyanine dye N744 inhibits tau fibrillization by blocking filament extension: implications for the treatment of tauopathic neurodegenerative diseases","volume":"44","author":"Necula","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.nurt.2008.05.006_bib162","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1021\/bi036094h","article-title":"Ligand-dependent inhibition and reversal of tau filament formation","volume":"43","author":"Chirita","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.nurt.2008.05.006_bib163","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbrc.2007.08.166","article-title":"Potent inhibition of tau fibrillization with a multivalent ligand","volume":"363","author":"Honson","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nurt.2008.05.006_bib164","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1073\/pnas.2627988100","article-title":"Potent inhibition of scrapie prion replication in cultured cells by bis-acridines","volume":"100","author":"May","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.05.006_bib165","doi-asserted-by":"crossref","first-page":"10311","DOI":"10.1074\/jbc.M608207200","article-title":"Small molecule inhibitors of aggregation indicate that amyloid \u03b2 oligomerization and fibrillization pathways are independent and distinct","volume":"282","author":"Necula","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib166","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/hmg\/11.9.1107","article-title":"Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy","volume":"11","author":"Ravikumar","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nurt.2008.05.006_bib167","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","article-title":"Autophagy as a regulated pathway of cellular degradation","volume":"290","author":"Klionsky","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.nurt.2008.05.006_bib168","doi-asserted-by":"crossref","first-page":"25009","DOI":"10.1074\/jbc.M300227200","article-title":"\u03b1-Synuclein is degraded by both autophagy and the proteasome","volume":"278","author":"Webb","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib169","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/hmg\/ddi458","article-title":"Rapamycin alleviates toxicity of different aggregate-prone proteins","volume":"15","author":"Berger","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nurt.2008.05.006_bib170","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/hmg\/ddm320","article-title":"Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases","volume":"17","author":"Tan","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nurt.2008.05.006_bib171","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4161\/auto.1.3.2050","article-title":"Dyneins, autophagy, aggregation and neurodegeneration","volume":"1","author":"Rubinsztein","year":"2005","journal-title":"Autophagy"},{"key":"10.1016\/j.nurt.2008.05.006_bib172","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4161\/auto.1.1.1513","article-title":"Autophagy and its possible roles in nervous system diseases, damage and repair","volume":"1","author":"Rubinsztein","year":"2005","journal-title":"Autophagy"},{"key":"10.1016\/j.nurt.2008.05.006_bib173","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1096\/fj.05-5343fje","article-title":"HSP induction mediates selective clearance of tau phosphorylated at proline-directed Ser\/Thr sites but not KXGS (MARK) sites","volume":"20","author":"Dickey","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.nurt.2008.05.006_bib174","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.molmed.2004.04.006","article-title":"Therapeutic and diagnostic implications of Hsp90 activation","volume":"10","author":"Kamal","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.nurt.2008.05.006_bib175","doi-asserted-by":"crossref","first-page":"10825","DOI":"10.1074\/jbc.M512786200","article-title":"Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-Tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6 ubiquitin conjugation","volume":"281","author":"Cripps","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib176","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0896-6273(93)90063-W","article-title":"Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments","volume":"10","author":"Morishima-Kawashima","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.nurt.2008.05.006_bib177","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1074\/jbc.M305838200","article-title":"CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival","volume":"279","author":"Shimura","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib178","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1523\/JNEUROSCI.0746-06.2006","article-title":"Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species","volume":"26","author":"Dickey","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2008.05.006_bib179","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/hmg\/ddh083","article-title":"CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation","volume":"13","author":"Petrucelli","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nurt.2008.05.006_bib180","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1471-4159.2005.03272.x","article-title":"In vivo evidence of CHIP up-regulation attenuating tau aggregation","volume":"94","author":"Sahara","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.nurt.2008.05.006_bib181","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/hmg\/ddm030","article-title":"CHIP and HSPs interact with \u03b2-APP in a proteasome-dependent manner and influence A\u03b2 metabolism","volume":"16","author":"Kumar","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nurt.2008.05.006_bib182","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.neuron.2006.07.019","article-title":"A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration","volume":"51","author":"Karsten","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.nurt.2008.05.006_bib183","doi-asserted-by":"crossref","first-page":"26931","DOI":"10.1074\/jbc.270.45.26931","article-title":"Puromycin-sensitive aminopeptidase: sequence analysis, expression, and functional characterization","volume":"270","author":"Constam","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib184","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1471-4159.1985.tb08779.x","article-title":"Characterization of membrane-bound aminopeptidases from rat brain: identification of the enkephalin-degrading aminopeptidase","volume":"44","author":"Hersh","year":"1985","journal-title":"J Neurochem"},{"key":"10.1016\/j.nurt.2008.05.006_bib185","doi-asserted-by":"crossref","first-page":"15111","DOI":"10.1021\/bi061830d","article-title":"Degradation of tau protein by puromycin-sensitive aminopeptidase in vitro","volume":"45","author":"Sengupta","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.nurt.2008.05.006_bib186","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1523\/JNEUROSCI.1125-05.2005","article-title":"The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates \u03b2-amyloid-induced neurodegeneration","volume":"25","author":"Park","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2008.05.006_bib187","doi-asserted-by":"crossref","first-page":"10032","DOI":"10.1073\/pnas.1630428100","article-title":"Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease","volume":"100","author":"Gamblin","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.05.006_bib188","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI200420640","article-title":"Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology","volume":"114","author":"Rissman","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nurt.2008.05.006_bib189","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/JAD-2005-7102","article-title":"Apoptotic effect of caspase-3 cleaved tau in hippocampal neurons and its potentiation by tau FTDP-mutation N279K","volume":"7","author":"Fasulo","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.nurt.2008.05.006_bib190","doi-asserted-by":"crossref","first-page":"20315","DOI":"10.1074\/jbc.M601016200","article-title":"ERK1\/2 activation mediates A\u03b2 oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures","volume":"281","author":"Chong","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib191","first-page":"887","article-title":"Radioimmunoassays for Ig classes G, A, M, D, and E in spinal fluids: normal values of different age groups","volume":"86","author":"Nerenberg","year":"1975","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.nurt.2008.05.006_bib192","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/exnr.1993.1059","article-title":"Serum proteins bypass the blood\u2013brain fluid barriers for extracellular entry to the central nervous system","volume":"120","author":"Broadwell","year":"1993","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nurt.2008.05.006_bib193","first-page":"9","article-title":"Circulating neuroactive peptides and the blood\u2013brain and blood-cerebrospinal fluid barriers","volume":"24","author":"Zlokovic","year":"1990","journal-title":"Endocrinol Exp"},{"key":"10.1016\/j.nurt.2008.05.006_bib194","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1097\/00001756-200110290-00011","article-title":"Amyloid \u03b2 peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood\u2013brain barrier","volume":"12","author":"Poduslo","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.nurt.2008.05.006_bib195","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jneumeth.2004.04.026","article-title":"Method for measurement of the blood\u2013brain barrier permeability in the perfused mouse brain: application to amyloid-\u03b2 peptide in wild type and Alzheimer's Tg2576 mice","volume":"138","author":"LaRue","year":"2004","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.nurt.2008.05.006_bib196","doi-asserted-by":"crossref","first-page":"9115","DOI":"10.1523\/JNEUROSCI.2361-07.2007","article-title":"Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements","volume":"27","author":"Asuni","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2008.05.006_bib197","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1001\/archneur.63.10.1459","article-title":"Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein","volume":"63","author":"Rosenmann","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nurt.2008.05.006_bib198","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1097\/00001756-200409150-00007","article-title":"Expression of Fc\u03b5 receptor I on primary sensory neurons in mice","volume":"15","author":"Andoh","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.nurt.2008.05.006_bib199","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0022-510X(86)90150-4","article-title":"Intraneuronal IgG in the central nervous system","volume":"73","author":"Fabian","year":"1986","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nurt.2008.05.006_bib200","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1212\/WNL.37.11.1780","article-title":"Intraneuronal IgG in the central nervous system: uptake by retrograde axonal transport","volume":"37","author":"Fabian","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.05.006_bib201","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1073\/pnas.89.15.7252","article-title":"Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system","volume":"89","author":"Dietzschold","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.05.006_bib202","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/cne.903420402","article-title":"Immunocytochemical localization of immunoglobulins in the rat brain: relationship to the blood\u2013brain barrier","volume":"342","author":"Aihara","year":"1994","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.nurt.2008.05.006_bib203","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jnr.10271","article-title":"Immunoglobulin Fc\u03b3 receptor promotes immunoglobulin uptake, immunoglobulin-mediated calcium increase, and neurotransmitter release in motor neurons","volume":"69","author":"Mohamed","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.nurt.2008.05.006_bib204","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/jps.20178","article-title":"Antibody pharmacokinetics and pharmacodynamics","volume":"93","author":"Lobo","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nurt.2008.05.006_bib205","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuron.2005.05.010","article-title":"Effects of \u03b1-synuclein immunization in a mouse model of Parkinson's disease","volume":"46","author":"Masliah","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.nurt.2008.05.006_bib206","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after A\u03b242 immunization","volume":"61","author":"Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.05.006_bib207","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.molbrainres.2005.02.014","article-title":"Quantitative analysis of tau isoform transcripts in sporadic tauopathies","volume":"137","author":"Connell","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.nurt.2008.05.006_bib208","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s004019900177","article-title":"A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease","volume":"100","author":"Ishizawa","year":"2000","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nurt.2008.05.006_bib209","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1750-3639.1999.tb00550.x","article-title":"Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease","volume":"9","author":"Bu\u00e9e","year":"1999","journal-title":"Brain Pathol"},{"key":"10.1016\/j.nurt.2008.05.006_bib210","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0169-328X(02)00382-0","article-title":"Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration","volume":"104","author":"Takanashi","year":"2002","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.nurt.2008.05.006_bib211","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/1531-8249(199909)46:3<325::AID-ANA8>3.0.CO;2-V","article-title":"Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease","volume":"46","author":"Chambers","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2008.05.006_bib212","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1093\/hmg\/ddl429","article-title":"Haplotype-specific expression of exon 10 at the human MAPT locus","volume":"15","author":"Caffrey","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nurt.2008.05.006_bib213","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.febslet.2004.09.011","article-title":"Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease","volume":"576","author":"Boutajangout","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nurt.2008.05.006_bib214","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1471-4159.2005.03552.x","article-title":"The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease","volume":"96","author":"Glatz","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.nurt.2008.05.006_bib215","doi-asserted-by":"crossref","first-page":"42986","DOI":"10.1074\/jbc.M105113200","article-title":"Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17","volume":"276","author":"Kalbfuss","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.006_bib216","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/6986","article-title":"Spliceosome-mediated RNA trans-splicing as a tool for gene therapy","volume":"17","author":"Puttaraju","year":"1999","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nurt.2008.05.006_bib217","doi-asserted-by":"crossref","first-page":"15659","DOI":"10.1073\/pnas.0503150102","article-title":"Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: implications for tauopathies","volume":"102","author":"Rodriguez-Martin","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.05.006_bib218","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nbt0102-47","article-title":"Partial correction of endogenous \u0394F508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing","volume":"20","author":"Liu","year":"2002","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nurt.2008.05.006_bib219","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nm900","article-title":"Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing","volume":"9","author":"Chao","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.nurt.2008.05.006_bib220","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0896-6273(00)81127-7","article-title":"Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform","volume":"24","author":"Ishihara","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.nurt.2008.05.006_bib221","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1083\/jcb.91.2.479","article-title":"Taxol binds to polymerized tubulin in vitro","volume":"91","author":"Parness","year":"1981","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nurt.2008.05.006_bib222","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1073\/pnas.0406361102","article-title":"Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model","volume":"102","author":"Zhang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.05.006_bib223","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2174\/1567205053585837","article-title":"Cytoskeletal integrity as a drug target","volume":"2","author":"Michaelis","year":"2005","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.nurt.2008.05.006_bib224","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/156720506777632880","article-title":"Ongoing in vivo studies with cytoskeletal drugs in tau transgenic mice","volume":"3","author":"Michaelis","year":"2006","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.nurt.2008.05.006_bib225","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1124\/jpet.107.130526","article-title":"A neuronal microtubule interacting agent, NAP, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease","volume":"325","author":"Matsuoka","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nurt.2008.05.006_bib226","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","article-title":"Reducing endogenous tau ameliorates amyloid \u03b2-induced deficits in an Alzheimer's disease mouse model","volume":"316","author":"Roberson","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.nurt.2008.05.006_bib227","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1212\/WNL.56.suppl_4.S21","article-title":"Missense and splice site mutations in tau associated with FTDP-17: multiple pathogenic mechanisms","volume":"56","author":"Hutton","year":"2001","journal-title":"Neurology"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923004944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923004944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1016\/j.nurt.2008.05.006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:37:54Z","timestamp":1761806274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923004944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":227,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S1878747923004944"],"URL":"https:\/\/doi.org\/10.1016\/j.nurt.2008.05.006","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tau-Based Treatment Strategies in Neurodegenerative Diseases","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nurt.2008.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}